SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a multi-year partnership with Sanofi (NASDAQ: SNY), an innovative ...
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the launch of the Viz Pulmonary™ Suite, an integrated AI-powered solution in the Viz.ai enterprise ...
A Vietnamese doctor and his colleague check X-rays of a drug-resistant tuberculosis patient at the National Lung Hospital in Hanoi - Copyright AFP Brendan SMIALOWSKI ...
Please provide your email address to receive an email when new articles are posted on . Researchers trained a convolutional neural network with ECGs from patients with COPD and controls to detect COPD ...
A new diagnostic framework for chronic obstructive pulmonary disease (COPD) that incorporates chest CT imaging and symptom assessment has redefined patient classification in large cohort studies, ...
Researchers have developed a new COPD diagnostic framework that uses chest CT imaging and symptom assessment alongside traditional lung function tests, identifying at-risk patients missed by ...
Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm, an AI-enabled software-as-a-medical-device ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results